| Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised … S Rts The Lancet 386 (9988), 31-45, 2015 | 1086 | 2015 |
| First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children RTS, S Clinical Trials Partnership New England Journal of Medicine 365 (20), 1863-1875, 2011 | 1021 | 2011 |
| A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants RTS, S Clinical Trials Partnership New England Journal of Medicine 367 (24), 2284-2295, 2012 | 886 | 2012 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 517 | 2016 |
| Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma B McCloskey, A Zumla, G Ippolito, L Blumberg, P Arbon, A Cicero, ... The Lancet 395 (10230), 1096-1099, 2020 | 489 | 2020 |
| Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ... New England Journal of Medicine 373 (21), 2025-2037, 2015 | 453 | 2015 |
| Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ... The Lancet infectious diseases 15 (12), 1450-1458, 2015 | 375 | 2015 |
| Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites RTS, S Clinical Trials Partnership (2014) PLoS medicine 11 (7), e1001685, 2014 | 369 | 2014 |
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial A Huttner, JA Dayer, S Yerly, C Combescure, F Auderset, J Desmeules, ... The Lancet Infectious Diseases 15 (10), 1156-1166, 2015 | 329 | 2015 |
| Safety and efficacy of the RTS, S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase … KP Asante, S Abdulla, S Agnandji, J Lyimo, J Vekemans, ... The Lancet infectious diseases 11 (10), 741-749, 2011 | 178 | 2011 |
| Placental malaria increases malaria risk in the first 30 months of life NG Schwarz, AA Adegnika, LP Breitling, J Gabor, ST Agnandji, ... Clinical Infectious Diseases 47 (8), 1017-1025, 2008 | 165 | 2008 |
| Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight AA Adegnika, JJ Verweij, ST Agnandji, SK Chai, LP Breitling, ... American Journal of Tropical Medicine and Hygiene 75 (5), 798-803, 2006 | 149 | 2006 |
| Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS, S/AS01E malaria vaccine efficacy C Dobaño, H Sanz, H Sorgho, D Dosoo, M Mpina, I Ubillos, R Aguilar, ... Nature communications 10 (1), 2174, 2019 | 137 | 2019 |
| Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV A Rechtien, L Richert, H Lorenzo, G Martrus, B Hejblum, C Dahlke, ... Cell reports 20 (9), 2251-2261, 2017 | 131 | 2017 |
| Epidemiology of parasitic co‐infections during pregnancy in Lambaréné, Gabon AA Adegnika, M Ramharter, ST Agnandji, U Ateba Ngoa, S Issifou, ... Tropical Medicine & International Health 15 (10), 1204-1209, 2010 | 130 | 2010 |
| Efficacy of RTS, S malaria vaccines: individual-participant pooled analysis of phase 2 data P Bejon, MT White, A Olotu, K Bojang, JPA Lusingu, N Salim, NN Otsyula, ... The Lancet infectious diseases 13 (4), 319-327, 2013 | 126 | 2013 |
| Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study G Mombo-Ngoma, JR Mackanga, R González, S Ouedraogo, ... BMJ open 6 (6), e011783, 2016 | 118 | 2016 |
| A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS, S malaria vaccine candidates in children in Gabon B Lell, S Agnandji, I Von Glasenapp, S Haertle, S Oyakhiromen, S Issifou, ... PLoS one 4 (10), e7611, 2009 | 117 | 2009 |
| Intermittent preventive treatment against malaria in infants in Gabon-a randomized, double-blind, placebo-controlled trial MP Grobusch, B Lell, NG Schwarz, J Gabor, J Dörnemann, M Pötschke, ... The Journal of infectious diseases 196 (11), 1595-1602, 2007 | 104 | 2007 |
| A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS, S malaria vaccine MT White, P Bejon, A Olotu, JT Griffin, K Bojang, J Lusingu, N Salim, ... BMC medicine 12, 1-11, 2014 | 98 | 2014 |
